Estimates of Mean Absorbed Radiation Dose in Prostate Cancer Patients and Healthy Volunteers
Target organ | 123I-MIP-1072 prostate cancer patients (mGy/MBq) | 123I-MIP-1095 prostate cancer patients (mGy/MBq) | 123I-MIP-1072 healthy volunteers (mGy/MBq) |
Urinary bladder wall* | 0.092 | 0.021 | 0.120 |
Salivary glands† | 0.058 | 0.160 | 0.224 |
Kidneys | 0.054 | 0.110 | 0.052 |
Distal colon | 0.046 | 0.072 | 0.036 |
Proximal colon | 0.040 | 0.066 | 0.030 |
Thyroid‡ | 0.038 | 0.100 | 0.071 |
Liver | 0.024 | 0.058 | 0.021 |
Spleen | 0.023 | 0.047 | 0.015 |
Small intestine | 0.021 | 0.033 | 0.016 |
Osteogenic cells | 0.019 | 0.030 | 0.014 |
Heart wall | 0.016 | 0.034 | 0.009 |
Lungs | 0.015 | 0.032 | 0.010 |
Gallbladder wall | 0.014 | 0.027 | 0.011 |
Pancreas | 0.011 | 0.020 | 0.008 |
Adrenals | 0.011 | 0.020 | 0.009 |
Stomach wall | 0.009 | 0.015 | 0.007 |
Muscle | 0.007 | 0.011 | 0.006 |
Testes | 0.007 | 0.008 | 0.006 |
Red marrow | 0.007 | 0.011 | 0.005 |
Thymus | 0.006 | 0.011 | 0.005 |
Skin | 0.004 | 0.007 | 0.003 |
Brain | 0.003 | 0.006 | 0.002 |
Total body | 0.009 | 0.014 | 0.007 |
Effective dose equivalent (mSv/MBq) | 0.025 | 0.037 | 0.024 |
Effective dose (mSv/MBq) | 0.022 | 0.032 | 0.021 |